Global Viral Vector and Plasmid DNA Market Research Report 2024(Status and Outlook)
Report Overview:
Viral vectors carry genetic material into cells by exploiting the molecular mechanisms by which viruses transmit their genomes to other cells for infection.It can occur in vivo or in vitro.Plasmid carriers are plasmids artificially constructed on the basis of natural plasmids to adapt to laboratory operations.In recent years, global viral vector and plasmid DNA manufacturing has developed rapidly, with a compound growth rate of about 28% during 2018-2018.In 2018, global sales of viral vector and plasmid DNA production reached $381 million.In 2018, China accounted for about 4% of global sales.In the next five years, the production of viral vectors and plasmid DNA products in China will continue to grow rapidly.Viral vector and plasmid DNA manufacturing are mainly divided into viral vector manufacturing and plasmid DNA manufacturing, among which viral vector manufacturing accounts for the largest proportion, accounting for nearly 38% of the total market in 2018.Viral vector and plasmid DNA manufacturing is mainly used for drug development and production of cancer, genetic diseases, viral infections and other diseases, among which cancer is the main application field, accounting for 35% in 2018.The market is highly competitive.Brammer Bio, Oxford BioMedica, Cobra Biologics, FinVector and Lonza are major suppliers.They have mastered key technologies and patents, and they have a fixed customer base. They have established a monopoly in the market.Gene therapy technology innovation and clinical trials have mushroomed in recent years, and a number of gene therapy projects have been approved for marketing in the United States, the European Union, China and other countries.The target of gene therapy has also been gradually expanded from single gene genetic diseases to malignant tumors, infectious diseases, cardiovascular diseases, autoimmune diseases, metabolic diseases and other major diseases.
The Global Viral Vector and Plasmid DNA Market Size was estimated at USD 808.98 million in 2023 and is projected to reach USD 2332.29 million by 2029, exhibiting a CAGR of 19.30% during the forecast period.
This report provides a deep insight into the global Viral Vector and Plasmid DNA market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Viral Vector and Plasmid DNA Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Viral Vector and Plasmid DNA market in any manner.
Global Viral Vector and Plasmid DNA Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Brammer Bio
Oxford BioMedica
Cobra Biologics
FinVector
Lonza
BioReliance
MolMed
FUJIFILM Diosynth Biotechnologies
UniQure
Aldevron
Richter-Helm
Eurogentec
OBiO Technology
Yposkesi
Cell and Gene Therapy Catapult
MassBiologics
Biovian
VGXI
Gene Synthesis
PlasmidFactory
Jikai Gene
Market Segmentation (by Type)
Plasmid DNA
Viral Vector
Market Segmentation (by Application)
Cancer
Virus Infection
Hereditary Disease
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Viral Vector and Plasmid DNA Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Viral vectors carry genetic material into cells by exploiting the molecular mechanisms by which viruses transmit their genomes to other cells for infection.It can occur in vivo or in vitro.Plasmid carriers are plasmids artificially constructed on the basis of natural plasmids to adapt to laboratory operations.In recent years, global viral vector and plasmid DNA manufacturing has developed rapidly, with a compound growth rate of about 28% during 2018-2018.In 2018, global sales of viral vector and plasmid DNA production reached $381 million.In 2018, China accounted for about 4% of global sales.In the next five years, the production of viral vectors and plasmid DNA products in China will continue to grow rapidly.Viral vector and plasmid DNA manufacturing are mainly divided into viral vector manufacturing and plasmid DNA manufacturing, among which viral vector manufacturing accounts for the largest proportion, accounting for nearly 38% of the total market in 2018.Viral vector and plasmid DNA manufacturing is mainly used for drug development and production of cancer, genetic diseases, viral infections and other diseases, among which cancer is the main application field, accounting for 35% in 2018.The market is highly competitive.Brammer Bio, Oxford BioMedica, Cobra Biologics, FinVector and Lonza are major suppliers.They have mastered key technologies and patents, and they have a fixed customer base. They have established a monopoly in the market.Gene therapy technology innovation and clinical trials have mushroomed in recent years, and a number of gene therapy projects have been approved for marketing in the United States, the European Union, China and other countries.The target of gene therapy has also been gradually expanded from single gene genetic diseases to malignant tumors, infectious diseases, cardiovascular diseases, autoimmune diseases, metabolic diseases and other major diseases.
The Global Viral Vector and Plasmid DNA Market Size was estimated at USD 808.98 million in 2023 and is projected to reach USD 2332.29 million by 2029, exhibiting a CAGR of 19.30% during the forecast period.
This report provides a deep insight into the global Viral Vector and Plasmid DNA market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Viral Vector and Plasmid DNA Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Viral Vector and Plasmid DNA market in any manner.
Global Viral Vector and Plasmid DNA Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Brammer Bio
Oxford BioMedica
Cobra Biologics
FinVector
Lonza
BioReliance
MolMed
FUJIFILM Diosynth Biotechnologies
UniQure
Aldevron
Richter-Helm
Eurogentec
OBiO Technology
Yposkesi
Cell and Gene Therapy Catapult
MassBiologics
Biovian
VGXI
Gene Synthesis
PlasmidFactory
Jikai Gene
Market Segmentation (by Type)
Plasmid DNA
Viral Vector
Market Segmentation (by Application)
Cancer
Virus Infection
Hereditary Disease
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Viral Vector and Plasmid DNA Market
- Overview of the regional outlook of the Viral Vector and Plasmid DNA Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Viral Vector and Plasmid DNA Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Viral Vector and Plasmid DNA
1.2 Key Market Segments
1.2.1 Viral Vector and Plasmid DNA Segment by Type
1.2.2 Viral Vector and Plasmid DNA Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 VIRAL VECTOR AND PLASMID DNA MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Viral Vector and Plasmid DNA Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Viral Vector and Plasmid DNA Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 VIRAL VECTOR AND PLASMID DNA MARKET COMPETITIVE LANDSCAPE
3.1 Global Viral Vector and Plasmid DNA Sales by Manufacturers (2019-2024)
3.2 Global Viral Vector and Plasmid DNA Revenue Market Share by Manufacturers (2019-2024)
3.3 Viral Vector and Plasmid DNA Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Viral Vector and Plasmid DNA Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Viral Vector and Plasmid DNA Sales Sites, Area Served, Product Type
3.6 Viral Vector and Plasmid DNA Market Competitive Situation and Trends
3.6.1 Viral Vector and Plasmid DNA Market Concentration Rate
3.6.2 Global 5 and 10 Largest Viral Vector and Plasmid DNA Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 VIRAL VECTOR AND PLASMID DNA INDUSTRY CHAIN ANALYSIS
4.1 Viral Vector and Plasmid DNA Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF VIRAL VECTOR AND PLASMID DNA MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 VIRAL VECTOR AND PLASMID DNA MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Viral Vector and Plasmid DNA Sales Market Share by Type (2019-2024)
6.3 Global Viral Vector and Plasmid DNA Market Size Market Share by Type (2019-2024)
6.4 Global Viral Vector and Plasmid DNA Price by Type (2019-2024)
7 VIRAL VECTOR AND PLASMID DNA MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Viral Vector and Plasmid DNA Market Sales by Application (2019-2024)
7.3 Global Viral Vector and Plasmid DNA Market Size (M USD) by Application (2019-2024)
7.4 Global Viral Vector and Plasmid DNA Sales Growth Rate by Application (2019-2024)
8 VIRAL VECTOR AND PLASMID DNA MARKET SEGMENTATION BY REGION
8.1 Global Viral Vector and Plasmid DNA Sales by Region
8.1.1 Global Viral Vector and Plasmid DNA Sales by Region
8.1.2 Global Viral Vector and Plasmid DNA Sales Market Share by Region
8.2 North America
8.2.1 North America Viral Vector and Plasmid DNA Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Viral Vector and Plasmid DNA Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Viral Vector and Plasmid DNA Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Viral Vector and Plasmid DNA Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Viral Vector and Plasmid DNA Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Brammer Bio
9.1.1 Brammer Bio Viral Vector and Plasmid DNA Basic Information
9.1.2 Brammer Bio Viral Vector and Plasmid DNA Product Overview
9.1.3 Brammer Bio Viral Vector and Plasmid DNA Product Market Performance
9.1.4 Brammer Bio Business Overview
9.1.5 Brammer Bio Viral Vector and Plasmid DNA SWOT Analysis
9.1.6 Brammer Bio Recent Developments
9.2 Oxford BioMedica
9.2.1 Oxford BioMedica Viral Vector and Plasmid DNA Basic Information
9.2.2 Oxford BioMedica Viral Vector and Plasmid DNA Product Overview
9.2.3 Oxford BioMedica Viral Vector and Plasmid DNA Product Market Performance
9.2.4 Oxford BioMedica Business Overview
9.2.5 Oxford BioMedica Viral Vector and Plasmid DNA SWOT Analysis
9.2.6 Oxford BioMedica Recent Developments
9.3 Cobra Biologics
9.3.1 Cobra Biologics Viral Vector and Plasmid DNA Basic Information
9.3.2 Cobra Biologics Viral Vector and Plasmid DNA Product Overview
9.3.3 Cobra Biologics Viral Vector and Plasmid DNA Product Market Performance
9.3.4 Cobra Biologics Viral Vector and Plasmid DNA SWOT Analysis
9.3.5 Cobra Biologics Business Overview
9.3.6 Cobra Biologics Recent Developments
9.4 FinVector
9.4.1 FinVector Viral Vector and Plasmid DNA Basic Information
9.4.2 FinVector Viral Vector and Plasmid DNA Product Overview
9.4.3 FinVector Viral Vector and Plasmid DNA Product Market Performance
9.4.4 FinVector Business Overview
9.4.5 FinVector Recent Developments
9.5 Lonza
9.5.1 Lonza Viral Vector and Plasmid DNA Basic Information
9.5.2 Lonza Viral Vector and Plasmid DNA Product Overview
9.5.3 Lonza Viral Vector and Plasmid DNA Product Market Performance
9.5.4 Lonza Business Overview
9.5.5 Lonza Recent Developments
9.6 BioReliance
9.6.1 BioReliance Viral Vector and Plasmid DNA Basic Information
9.6.2 BioReliance Viral Vector and Plasmid DNA Product Overview
9.6.3 BioReliance Viral Vector and Plasmid DNA Product Market Performance
9.6.4 BioReliance Business Overview
9.6.5 BioReliance Recent Developments
9.7 MolMed
9.7.1 MolMed Viral Vector and Plasmid DNA Basic Information
9.7.2 MolMed Viral Vector and Plasmid DNA Product Overview
9.7.3 MolMed Viral Vector and Plasmid DNA Product Market Performance
9.7.4 MolMed Business Overview
9.7.5 MolMed Recent Developments
9.8 FUJIFILM Diosynth Biotechnologies
9.8.1 FUJIFILM Diosynth Biotechnologies Viral Vector and Plasmid DNA Basic Information
9.8.2 FUJIFILM Diosynth Biotechnologies Viral Vector and Plasmid DNA Product Overview
9.8.3 FUJIFILM Diosynth Biotechnologies Viral Vector and Plasmid DNA Product Market Performance
9.8.4 FUJIFILM Diosynth Biotechnologies Business Overview
9.8.5 FUJIFILM Diosynth Biotechnologies Recent Developments
9.9 UniQure
9.9.1 UniQure Viral Vector and Plasmid DNA Basic Information
9.9.2 UniQure Viral Vector and Plasmid DNA Product Overview
9.9.3 UniQure Viral Vector and Plasmid DNA Product Market Performance
9.9.4 UniQure Business Overview
9.9.5 UniQure Recent Developments
9.10 Aldevron
9.10.1 Aldevron Viral Vector and Plasmid DNA Basic Information
9.10.2 Aldevron Viral Vector and Plasmid DNA Product Overview
9.10.3 Aldevron Viral Vector and Plasmid DNA Product Market Performance
9.10.4 Aldevron Business Overview
9.10.5 Aldevron Recent Developments
9.11 Richter-Helm
9.11.1 Richter-Helm Viral Vector and Plasmid DNA Basic Information
9.11.2 Richter-Helm Viral Vector and Plasmid DNA Product Overview
9.11.3 Richter-Helm Viral Vector and Plasmid DNA Product Market Performance
9.11.4 Richter-Helm Business Overview
9.11.5 Richter-Helm Recent Developments
9.12 Eurogentec
9.12.1 Eurogentec Viral Vector and Plasmid DNA Basic Information
9.12.2 Eurogentec Viral Vector and Plasmid DNA Product Overview
9.12.3 Eurogentec Viral Vector and Plasmid DNA Product Market Performance
9.12.4 Eurogentec Business Overview
9.12.5 Eurogentec Recent Developments
9.13 OBiO Technology
9.13.1 OBiO Technology Viral Vector and Plasmid DNA Basic Information
9.13.2 OBiO Technology Viral Vector and Plasmid DNA Product Overview
9.13.3 OBiO Technology Viral Vector and Plasmid DNA Product Market Performance
9.13.4 OBiO Technology Business Overview
9.13.5 OBiO Technology Recent Developments
9.14 Yposkesi
9.14.1 Yposkesi Viral Vector and Plasmid DNA Basic Information
9.14.2 Yposkesi Viral Vector and Plasmid DNA Product Overview
9.14.3 Yposkesi Viral Vector and Plasmid DNA Product Market Performance
9.14.4 Yposkesi Business Overview
9.14.5 Yposkesi Recent Developments
9.15 Cell and Gene Therapy Catapult
9.15.1 Cell and Gene Therapy Catapult Viral Vector and Plasmid DNA Basic Information
9.15.2 Cell and Gene Therapy Catapult Viral Vector and Plasmid DNA Product Overview
9.15.3 Cell and Gene Therapy Catapult Viral Vector and Plasmid DNA Product Market Performance
9.15.4 Cell and Gene Therapy Catapult Business Overview
9.15.5 Cell and Gene Therapy Catapult Recent Developments
9.16 MassBiologics
9.16.1 MassBiologics Viral Vector and Plasmid DNA Basic Information
9.16.2 MassBiologics Viral Vector and Plasmid DNA Product Overview
9.16.3 MassBiologics Viral Vector and Plasmid DNA Product Market Performance
9.16.4 MassBiologics Business Overview
9.16.5 MassBiologics Recent Developments
9.17 Biovian
9.17.1 Biovian Viral Vector and Plasmid DNA Basic Information
9.17.2 Biovian Viral Vector and Plasmid DNA Product Overview
9.17.3 Biovian Viral Vector and Plasmid DNA Product Market Performance
9.17.4 Biovian Business Overview
9.17.5 Biovian Recent Developments
9.18 VGXI
9.18.1 VGXI Viral Vector and Plasmid DNA Basic Information
9.18.2 VGXI Viral Vector and Plasmid DNA Product Overview
9.18.3 VGXI Viral Vector and Plasmid DNA Product Market Performance
9.18.4 VGXI Business Overview
9.18.5 VGXI Recent Developments
9.19 Gene Synthesis
9.19.1 Gene Synthesis Viral Vector and Plasmid DNA Basic Information
9.19.2 Gene Synthesis Viral Vector and Plasmid DNA Product Overview
9.19.3 Gene Synthesis Viral Vector and Plasmid DNA Product Market Performance
9.19.4 Gene Synthesis Business Overview
9.19.5 Gene Synthesis Recent Developments
9.20 PlasmidFactory
9.20.1 PlasmidFactory Viral Vector and Plasmid DNA Basic Information
9.20.2 PlasmidFactory Viral Vector and Plasmid DNA Product Overview
9.20.3 PlasmidFactory Viral Vector and Plasmid DNA Product Market Performance
9.20.4 PlasmidFactory Business Overview
9.20.5 PlasmidFactory Recent Developments
9.21 Jikai Gene
9.21.1 Jikai Gene Viral Vector and Plasmid DNA Basic Information
9.21.2 Jikai Gene Viral Vector and Plasmid DNA Product Overview
9.21.3 Jikai Gene Viral Vector and Plasmid DNA Product Market Performance
9.21.4 Jikai Gene Business Overview
9.21.5 Jikai Gene Recent Developments
10 VIRAL VECTOR AND PLASMID DNA MARKET FORECAST BY REGION
10.1 Global Viral Vector and Plasmid DNA Market Size Forecast
10.2 Global Viral Vector and Plasmid DNA Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Viral Vector and Plasmid DNA Market Size Forecast by Country
10.2.3 Asia Pacific Viral Vector and Plasmid DNA Market Size Forecast by Region
10.2.4 South America Viral Vector and Plasmid DNA Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Viral Vector and Plasmid DNA by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Viral Vector and Plasmid DNA Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Viral Vector and Plasmid DNA by Type (2025-2030)
11.1.2 Global Viral Vector and Plasmid DNA Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Viral Vector and Plasmid DNA by Type (2025-2030)
11.2 Global Viral Vector and Plasmid DNA Market Forecast by Application (2025-2030)
11.2.1 Global Viral Vector and Plasmid DNA Sales (K Units) Forecast by Application
11.2.2 Global Viral Vector and Plasmid DNA Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Viral Vector and Plasmid DNA
1.2 Key Market Segments
1.2.1 Viral Vector and Plasmid DNA Segment by Type
1.2.2 Viral Vector and Plasmid DNA Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 VIRAL VECTOR AND PLASMID DNA MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Viral Vector and Plasmid DNA Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Viral Vector and Plasmid DNA Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 VIRAL VECTOR AND PLASMID DNA MARKET COMPETITIVE LANDSCAPE
3.1 Global Viral Vector and Plasmid DNA Sales by Manufacturers (2019-2024)
3.2 Global Viral Vector and Plasmid DNA Revenue Market Share by Manufacturers (2019-2024)
3.3 Viral Vector and Plasmid DNA Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Viral Vector and Plasmid DNA Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Viral Vector and Plasmid DNA Sales Sites, Area Served, Product Type
3.6 Viral Vector and Plasmid DNA Market Competitive Situation and Trends
3.6.1 Viral Vector and Plasmid DNA Market Concentration Rate
3.6.2 Global 5 and 10 Largest Viral Vector and Plasmid DNA Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 VIRAL VECTOR AND PLASMID DNA INDUSTRY CHAIN ANALYSIS
4.1 Viral Vector and Plasmid DNA Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF VIRAL VECTOR AND PLASMID DNA MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 VIRAL VECTOR AND PLASMID DNA MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Viral Vector and Plasmid DNA Sales Market Share by Type (2019-2024)
6.3 Global Viral Vector and Plasmid DNA Market Size Market Share by Type (2019-2024)
6.4 Global Viral Vector and Plasmid DNA Price by Type (2019-2024)
7 VIRAL VECTOR AND PLASMID DNA MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Viral Vector and Plasmid DNA Market Sales by Application (2019-2024)
7.3 Global Viral Vector and Plasmid DNA Market Size (M USD) by Application (2019-2024)
7.4 Global Viral Vector and Plasmid DNA Sales Growth Rate by Application (2019-2024)
8 VIRAL VECTOR AND PLASMID DNA MARKET SEGMENTATION BY REGION
8.1 Global Viral Vector and Plasmid DNA Sales by Region
8.1.1 Global Viral Vector and Plasmid DNA Sales by Region
8.1.2 Global Viral Vector and Plasmid DNA Sales Market Share by Region
8.2 North America
8.2.1 North America Viral Vector and Plasmid DNA Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Viral Vector and Plasmid DNA Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Viral Vector and Plasmid DNA Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Viral Vector and Plasmid DNA Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Viral Vector and Plasmid DNA Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Brammer Bio
9.1.1 Brammer Bio Viral Vector and Plasmid DNA Basic Information
9.1.2 Brammer Bio Viral Vector and Plasmid DNA Product Overview
9.1.3 Brammer Bio Viral Vector and Plasmid DNA Product Market Performance
9.1.4 Brammer Bio Business Overview
9.1.5 Brammer Bio Viral Vector and Plasmid DNA SWOT Analysis
9.1.6 Brammer Bio Recent Developments
9.2 Oxford BioMedica
9.2.1 Oxford BioMedica Viral Vector and Plasmid DNA Basic Information
9.2.2 Oxford BioMedica Viral Vector and Plasmid DNA Product Overview
9.2.3 Oxford BioMedica Viral Vector and Plasmid DNA Product Market Performance
9.2.4 Oxford BioMedica Business Overview
9.2.5 Oxford BioMedica Viral Vector and Plasmid DNA SWOT Analysis
9.2.6 Oxford BioMedica Recent Developments
9.3 Cobra Biologics
9.3.1 Cobra Biologics Viral Vector and Plasmid DNA Basic Information
9.3.2 Cobra Biologics Viral Vector and Plasmid DNA Product Overview
9.3.3 Cobra Biologics Viral Vector and Plasmid DNA Product Market Performance
9.3.4 Cobra Biologics Viral Vector and Plasmid DNA SWOT Analysis
9.3.5 Cobra Biologics Business Overview
9.3.6 Cobra Biologics Recent Developments
9.4 FinVector
9.4.1 FinVector Viral Vector and Plasmid DNA Basic Information
9.4.2 FinVector Viral Vector and Plasmid DNA Product Overview
9.4.3 FinVector Viral Vector and Plasmid DNA Product Market Performance
9.4.4 FinVector Business Overview
9.4.5 FinVector Recent Developments
9.5 Lonza
9.5.1 Lonza Viral Vector and Plasmid DNA Basic Information
9.5.2 Lonza Viral Vector and Plasmid DNA Product Overview
9.5.3 Lonza Viral Vector and Plasmid DNA Product Market Performance
9.5.4 Lonza Business Overview
9.5.5 Lonza Recent Developments
9.6 BioReliance
9.6.1 BioReliance Viral Vector and Plasmid DNA Basic Information
9.6.2 BioReliance Viral Vector and Plasmid DNA Product Overview
9.6.3 BioReliance Viral Vector and Plasmid DNA Product Market Performance
9.6.4 BioReliance Business Overview
9.6.5 BioReliance Recent Developments
9.7 MolMed
9.7.1 MolMed Viral Vector and Plasmid DNA Basic Information
9.7.2 MolMed Viral Vector and Plasmid DNA Product Overview
9.7.3 MolMed Viral Vector and Plasmid DNA Product Market Performance
9.7.4 MolMed Business Overview
9.7.5 MolMed Recent Developments
9.8 FUJIFILM Diosynth Biotechnologies
9.8.1 FUJIFILM Diosynth Biotechnologies Viral Vector and Plasmid DNA Basic Information
9.8.2 FUJIFILM Diosynth Biotechnologies Viral Vector and Plasmid DNA Product Overview
9.8.3 FUJIFILM Diosynth Biotechnologies Viral Vector and Plasmid DNA Product Market Performance
9.8.4 FUJIFILM Diosynth Biotechnologies Business Overview
9.8.5 FUJIFILM Diosynth Biotechnologies Recent Developments
9.9 UniQure
9.9.1 UniQure Viral Vector and Plasmid DNA Basic Information
9.9.2 UniQure Viral Vector and Plasmid DNA Product Overview
9.9.3 UniQure Viral Vector and Plasmid DNA Product Market Performance
9.9.4 UniQure Business Overview
9.9.5 UniQure Recent Developments
9.10 Aldevron
9.10.1 Aldevron Viral Vector and Plasmid DNA Basic Information
9.10.2 Aldevron Viral Vector and Plasmid DNA Product Overview
9.10.3 Aldevron Viral Vector and Plasmid DNA Product Market Performance
9.10.4 Aldevron Business Overview
9.10.5 Aldevron Recent Developments
9.11 Richter-Helm
9.11.1 Richter-Helm Viral Vector and Plasmid DNA Basic Information
9.11.2 Richter-Helm Viral Vector and Plasmid DNA Product Overview
9.11.3 Richter-Helm Viral Vector and Plasmid DNA Product Market Performance
9.11.4 Richter-Helm Business Overview
9.11.5 Richter-Helm Recent Developments
9.12 Eurogentec
9.12.1 Eurogentec Viral Vector and Plasmid DNA Basic Information
9.12.2 Eurogentec Viral Vector and Plasmid DNA Product Overview
9.12.3 Eurogentec Viral Vector and Plasmid DNA Product Market Performance
9.12.4 Eurogentec Business Overview
9.12.5 Eurogentec Recent Developments
9.13 OBiO Technology
9.13.1 OBiO Technology Viral Vector and Plasmid DNA Basic Information
9.13.2 OBiO Technology Viral Vector and Plasmid DNA Product Overview
9.13.3 OBiO Technology Viral Vector and Plasmid DNA Product Market Performance
9.13.4 OBiO Technology Business Overview
9.13.5 OBiO Technology Recent Developments
9.14 Yposkesi
9.14.1 Yposkesi Viral Vector and Plasmid DNA Basic Information
9.14.2 Yposkesi Viral Vector and Plasmid DNA Product Overview
9.14.3 Yposkesi Viral Vector and Plasmid DNA Product Market Performance
9.14.4 Yposkesi Business Overview
9.14.5 Yposkesi Recent Developments
9.15 Cell and Gene Therapy Catapult
9.15.1 Cell and Gene Therapy Catapult Viral Vector and Plasmid DNA Basic Information
9.15.2 Cell and Gene Therapy Catapult Viral Vector and Plasmid DNA Product Overview
9.15.3 Cell and Gene Therapy Catapult Viral Vector and Plasmid DNA Product Market Performance
9.15.4 Cell and Gene Therapy Catapult Business Overview
9.15.5 Cell and Gene Therapy Catapult Recent Developments
9.16 MassBiologics
9.16.1 MassBiologics Viral Vector and Plasmid DNA Basic Information
9.16.2 MassBiologics Viral Vector and Plasmid DNA Product Overview
9.16.3 MassBiologics Viral Vector and Plasmid DNA Product Market Performance
9.16.4 MassBiologics Business Overview
9.16.5 MassBiologics Recent Developments
9.17 Biovian
9.17.1 Biovian Viral Vector and Plasmid DNA Basic Information
9.17.2 Biovian Viral Vector and Plasmid DNA Product Overview
9.17.3 Biovian Viral Vector and Plasmid DNA Product Market Performance
9.17.4 Biovian Business Overview
9.17.5 Biovian Recent Developments
9.18 VGXI
9.18.1 VGXI Viral Vector and Plasmid DNA Basic Information
9.18.2 VGXI Viral Vector and Plasmid DNA Product Overview
9.18.3 VGXI Viral Vector and Plasmid DNA Product Market Performance
9.18.4 VGXI Business Overview
9.18.5 VGXI Recent Developments
9.19 Gene Synthesis
9.19.1 Gene Synthesis Viral Vector and Plasmid DNA Basic Information
9.19.2 Gene Synthesis Viral Vector and Plasmid DNA Product Overview
9.19.3 Gene Synthesis Viral Vector and Plasmid DNA Product Market Performance
9.19.4 Gene Synthesis Business Overview
9.19.5 Gene Synthesis Recent Developments
9.20 PlasmidFactory
9.20.1 PlasmidFactory Viral Vector and Plasmid DNA Basic Information
9.20.2 PlasmidFactory Viral Vector and Plasmid DNA Product Overview
9.20.3 PlasmidFactory Viral Vector and Plasmid DNA Product Market Performance
9.20.4 PlasmidFactory Business Overview
9.20.5 PlasmidFactory Recent Developments
9.21 Jikai Gene
9.21.1 Jikai Gene Viral Vector and Plasmid DNA Basic Information
9.21.2 Jikai Gene Viral Vector and Plasmid DNA Product Overview
9.21.3 Jikai Gene Viral Vector and Plasmid DNA Product Market Performance
9.21.4 Jikai Gene Business Overview
9.21.5 Jikai Gene Recent Developments
10 VIRAL VECTOR AND PLASMID DNA MARKET FORECAST BY REGION
10.1 Global Viral Vector and Plasmid DNA Market Size Forecast
10.2 Global Viral Vector and Plasmid DNA Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Viral Vector and Plasmid DNA Market Size Forecast by Country
10.2.3 Asia Pacific Viral Vector and Plasmid DNA Market Size Forecast by Region
10.2.4 South America Viral Vector and Plasmid DNA Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Viral Vector and Plasmid DNA by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Viral Vector and Plasmid DNA Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Viral Vector and Plasmid DNA by Type (2025-2030)
11.1.2 Global Viral Vector and Plasmid DNA Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Viral Vector and Plasmid DNA by Type (2025-2030)
11.2 Global Viral Vector and Plasmid DNA Market Forecast by Application (2025-2030)
11.2.1 Global Viral Vector and Plasmid DNA Sales (K Units) Forecast by Application
11.2.2 Global Viral Vector and Plasmid DNA Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Viral Vector and Plasmid DNA Market Size Comparison by Region (M USD)
Table 5. Global Viral Vector and Plasmid DNA Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Viral Vector and Plasmid DNA Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Viral Vector and Plasmid DNA Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Viral Vector and Plasmid DNA Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vector and Plasmid DNA as of 2022)
Table 10. Global Market Viral Vector and Plasmid DNA Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Viral Vector and Plasmid DNA Sales Sites and Area Served
Table 12. Manufacturers Viral Vector and Plasmid DNA Product Type
Table 13. Global Viral Vector and Plasmid DNA Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Viral Vector and Plasmid DNA
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Viral Vector and Plasmid DNA Market Challenges
Table 22. Global Viral Vector and Plasmid DNA Sales by Type (K Units)
Table 23. Global Viral Vector and Plasmid DNA Market Size by Type (M USD)
Table 24. Global Viral Vector and Plasmid DNA Sales (K Units) by Type (2019-2024)
Table 25. Global Viral Vector and Plasmid DNA Sales Market Share by Type (2019-2024)
Table 26. Global Viral Vector and Plasmid DNA Market Size (M USD) by Type (2019-2024)
Table 27. Global Viral Vector and Plasmid DNA Market Size Share by Type (2019-2024)
Table 28. Global Viral Vector and Plasmid DNA Price (USD/Unit) by Type (2019-2024)
Table 29. Global Viral Vector and Plasmid DNA Sales (K Units) by Application
Table 30. Global Viral Vector and Plasmid DNA Market Size by Application
Table 31. Global Viral Vector and Plasmid DNA Sales by Application (2019-2024) & (K Units)
Table 32. Global Viral Vector and Plasmid DNA Sales Market Share by Application (2019-2024)
Table 33. Global Viral Vector and Plasmid DNA Sales by Application (2019-2024) & (M USD)
Table 34. Global Viral Vector and Plasmid DNA Market Share by Application (2019-2024)
Table 35. Global Viral Vector and Plasmid DNA Sales Growth Rate by Application (2019-2024)
Table 36. Global Viral Vector and Plasmid DNA Sales by Region (2019-2024) & (K Units)
Table 37. Global Viral Vector and Plasmid DNA Sales Market Share by Region (2019-2024)
Table 38. North America Viral Vector and Plasmid DNA Sales by Country (2019-2024) & (K Units)
Table 39. Europe Viral Vector and Plasmid DNA Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Viral Vector and Plasmid DNA Sales by Region (2019-2024) & (K Units)
Table 41. South America Viral Vector and Plasmid DNA Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Viral Vector and Plasmid DNA Sales by Region (2019-2024) & (K Units)
Table 43. Brammer Bio Viral Vector and Plasmid DNA Basic Information
Table 44. Brammer Bio Viral Vector and Plasmid DNA Product Overview
Table 45. Brammer Bio Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Brammer Bio Business Overview
Table 47. Brammer Bio Viral Vector and Plasmid DNA SWOT Analysis
Table 48. Brammer Bio Recent Developments
Table 49. Oxford BioMedica Viral Vector and Plasmid DNA Basic Information
Table 50. Oxford BioMedica Viral Vector and Plasmid DNA Product Overview
Table 51. Oxford BioMedica Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Oxford BioMedica Business Overview
Table 53. Oxford BioMedica Viral Vector and Plasmid DNA SWOT Analysis
Table 54. Oxford BioMedica Recent Developments
Table 55. Cobra Biologics Viral Vector and Plasmid DNA Basic Information
Table 56. Cobra Biologics Viral Vector and Plasmid DNA Product Overview
Table 57. Cobra Biologics Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Cobra Biologics Viral Vector and Plasmid DNA SWOT Analysis
Table 59. Cobra Biologics Business Overview
Table 60. Cobra Biologics Recent Developments
Table 61. FinVector Viral Vector and Plasmid DNA Basic Information
Table 62. FinVector Viral Vector and Plasmid DNA Product Overview
Table 63. FinVector Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. FinVector Business Overview
Table 65. FinVector Recent Developments
Table 66. Lonza Viral Vector and Plasmid DNA Basic Information
Table 67. Lonza Viral Vector and Plasmid DNA Product Overview
Table 68. Lonza Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Lonza Business Overview
Table 70. Lonza Recent Developments
Table 71. BioReliance Viral Vector and Plasmid DNA Basic Information
Table 72. BioReliance Viral Vector and Plasmid DNA Product Overview
Table 73. BioReliance Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. BioReliance Business Overview
Table 75. BioReliance Recent Developments
Table 76. MolMed Viral Vector and Plasmid DNA Basic Information
Table 77. MolMed Viral Vector and Plasmid DNA Product Overview
Table 78. MolMed Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. MolMed Business Overview
Table 80. MolMed Recent Developments
Table 81. FUJIFILM Diosynth Biotechnologies Viral Vector and Plasmid DNA Basic Information
Table 82. FUJIFILM Diosynth Biotechnologies Viral Vector and Plasmid DNA Product Overview
Table 83. FUJIFILM Diosynth Biotechnologies Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. FUJIFILM Diosynth Biotechnologies Business Overview
Table 85. FUJIFILM Diosynth Biotechnologies Recent Developments
Table 86. UniQure Viral Vector and Plasmid DNA Basic Information
Table 87. UniQure Viral Vector and Plasmid DNA Product Overview
Table 88. UniQure Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. UniQure Business Overview
Table 90. UniQure Recent Developments
Table 91. Aldevron Viral Vector and Plasmid DNA Basic Information
Table 92. Aldevron Viral Vector and Plasmid DNA Product Overview
Table 93. Aldevron Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Aldevron Business Overview
Table 95. Aldevron Recent Developments
Table 96. Richter-Helm Viral Vector and Plasmid DNA Basic Information
Table 97. Richter-Helm Viral Vector and Plasmid DNA Product Overview
Table 98. Richter-Helm Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Richter-Helm Business Overview
Table 100. Richter-Helm Recent Developments
Table 101. Eurogentec Viral Vector and Plasmid DNA Basic Information
Table 102. Eurogentec Viral Vector and Plasmid DNA Product Overview
Table 103. Eurogentec Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Eurogentec Business Overview
Table 105. Eurogentec Recent Developments
Table 106. OBiO Technology Viral Vector and Plasmid DNA Basic Information
Table 107. OBiO Technology Viral Vector and Plasmid DNA Product Overview
Table 108. OBiO Technology Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. OBiO Technology Business Overview
Table 110. OBiO Technology Recent Developments
Table 111. Yposkesi Viral Vector and Plasmid DNA Basic Information
Table 112. Yposkesi Viral Vector and Plasmid DNA Product Overview
Table 113. Yposkesi Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Yposkesi Business Overview
Table 115. Yposkesi Recent Developments
Table 116. Cell and Gene Therapy Catapult Viral Vector and Plasmid DNA Basic Information
Table 117. Cell and Gene Therapy Catapult Viral Vector and Plasmid DNA Product Overview
Table 118. Cell and Gene Therapy Catapult Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Cell and Gene Therapy Catapult Business Overview
Table 120. Cell and Gene Therapy Catapult Recent Developments
Table 121. MassBiologics Viral Vector and Plasmid DNA Basic Information
Table 122. MassBiologics Viral Vector and Plasmid DNA Product Overview
Table 123. MassBiologics Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. MassBiologics Business Overview
Table 125. MassBiologics Recent Developments
Table 126. Biovian Viral Vector and Plasmid DNA Basic Information
Table 127. Biovian Viral Vector and Plasmid DNA Product Overview
Table 128. Biovian Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Biovian Business Overview
Table 130. Biovian Recent Developments
Table 131. VGXI Viral Vector and Plasmid DNA Basic Information
Table 132. VGXI Viral Vector and Plasmid DNA Product Overview
Table 133. VGXI Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. VGXI Business Overview
Table 135. VGXI Recent Developments
Table 136. Gene Synthesis Viral Vector and Plasmid DNA Basic Information
Table 137. Gene Synthesis Viral Vector and Plasmid DNA Product Overview
Table 138. Gene Synthesis Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. Gene Synthesis Business Overview
Table 140. Gene Synthesis Recent Developments
Table 141. PlasmidFactory Viral Vector and Plasmid DNA Basic Information
Table 142. PlasmidFactory Viral Vector and Plasmid DNA Product Overview
Table 143. PlasmidFactory Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 144. PlasmidFactory Business Overview
Table 145. PlasmidFactory Recent Developments
Table 146. Jikai Gene Viral Vector and Plasmid DNA Basic Information
Table 147. Jikai Gene Viral Vector and Plasmid DNA Product Overview
Table 148. Jikai Gene Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 149. Jikai Gene Business Overview
Table 150. Jikai Gene Recent Developments
Table 151. Global Viral Vector and Plasmid DNA Sales Forecast by Region (2025-2030) & (K Units)
Table 152. Global Viral Vector and Plasmid DNA Market Size Forecast by Region (2025-2030) & (M USD)
Table 153. North America Viral Vector and Plasmid DNA Sales Forecast by Country (2025-2030) & (K Units)
Table 154. North America Viral Vector and Plasmid DNA Market Size Forecast by Country (2025-2030) & (M USD)
Table 155. Europe Viral Vector and Plasmid DNA Sales Forecast by Country (2025-2030) & (K Units)
Table 156. Europe Viral Vector and Plasmid DNA Market Size Forecast by Country (2025-2030) & (M USD)
Table 157. Asia Pacific Viral Vector and Plasmid DNA Sales Forecast by Region (2025-2030) & (K Units)
Table 158. Asia Pacific Viral Vector and Plasmid DNA Market Size Forecast by Region (2025-2030) & (M USD)
Table 159. South America Viral Vector and Plasmid DNA Sales Forecast by Country (2025-2030) & (K Units)
Table 160. South America Viral Vector and Plasmid DNA Market Size Forecast by Country (2025-2030) & (M USD)
Table 161. Middle East and Africa Viral Vector and Plasmid DNA Consumption Forecast by Country (2025-2030) & (Units)
Table 162. Middle East and Africa Viral Vector and Plasmid DNA Market Size Forecast by Country (2025-2030) & (M USD)
Table 163. Global Viral Vector and Plasmid DNA Sales Forecast by Type (2025-2030) & (K Units)
Table 164. Global Viral Vector and Plasmid DNA Market Size Forecast by Type (2025-2030) & (M USD)
Table 165. Global Viral Vector and Plasmid DNA Price Forecast by Type (2025-2030) & (USD/Unit)
Table 166. Global Viral Vector and Plasmid DNA Sales (K Units) Forecast by Application (2025-2030)
Table 167. Global Viral Vector and Plasmid DNA Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Viral Vector and Plasmid DNA Market Size Comparison by Region (M USD)
Table 5. Global Viral Vector and Plasmid DNA Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Viral Vector and Plasmid DNA Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Viral Vector and Plasmid DNA Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Viral Vector and Plasmid DNA Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vector and Plasmid DNA as of 2022)
Table 10. Global Market Viral Vector and Plasmid DNA Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Viral Vector and Plasmid DNA Sales Sites and Area Served
Table 12. Manufacturers Viral Vector and Plasmid DNA Product Type
Table 13. Global Viral Vector and Plasmid DNA Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Viral Vector and Plasmid DNA
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Viral Vector and Plasmid DNA Market Challenges
Table 22. Global Viral Vector and Plasmid DNA Sales by Type (K Units)
Table 23. Global Viral Vector and Plasmid DNA Market Size by Type (M USD)
Table 24. Global Viral Vector and Plasmid DNA Sales (K Units) by Type (2019-2024)
Table 25. Global Viral Vector and Plasmid DNA Sales Market Share by Type (2019-2024)
Table 26. Global Viral Vector and Plasmid DNA Market Size (M USD) by Type (2019-2024)
Table 27. Global Viral Vector and Plasmid DNA Market Size Share by Type (2019-2024)
Table 28. Global Viral Vector and Plasmid DNA Price (USD/Unit) by Type (2019-2024)
Table 29. Global Viral Vector and Plasmid DNA Sales (K Units) by Application
Table 30. Global Viral Vector and Plasmid DNA Market Size by Application
Table 31. Global Viral Vector and Plasmid DNA Sales by Application (2019-2024) & (K Units)
Table 32. Global Viral Vector and Plasmid DNA Sales Market Share by Application (2019-2024)
Table 33. Global Viral Vector and Plasmid DNA Sales by Application (2019-2024) & (M USD)
Table 34. Global Viral Vector and Plasmid DNA Market Share by Application (2019-2024)
Table 35. Global Viral Vector and Plasmid DNA Sales Growth Rate by Application (2019-2024)
Table 36. Global Viral Vector and Plasmid DNA Sales by Region (2019-2024) & (K Units)
Table 37. Global Viral Vector and Plasmid DNA Sales Market Share by Region (2019-2024)
Table 38. North America Viral Vector and Plasmid DNA Sales by Country (2019-2024) & (K Units)
Table 39. Europe Viral Vector and Plasmid DNA Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Viral Vector and Plasmid DNA Sales by Region (2019-2024) & (K Units)
Table 41. South America Viral Vector and Plasmid DNA Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Viral Vector and Plasmid DNA Sales by Region (2019-2024) & (K Units)
Table 43. Brammer Bio Viral Vector and Plasmid DNA Basic Information
Table 44. Brammer Bio Viral Vector and Plasmid DNA Product Overview
Table 45. Brammer Bio Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Brammer Bio Business Overview
Table 47. Brammer Bio Viral Vector and Plasmid DNA SWOT Analysis
Table 48. Brammer Bio Recent Developments
Table 49. Oxford BioMedica Viral Vector and Plasmid DNA Basic Information
Table 50. Oxford BioMedica Viral Vector and Plasmid DNA Product Overview
Table 51. Oxford BioMedica Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Oxford BioMedica Business Overview
Table 53. Oxford BioMedica Viral Vector and Plasmid DNA SWOT Analysis
Table 54. Oxford BioMedica Recent Developments
Table 55. Cobra Biologics Viral Vector and Plasmid DNA Basic Information
Table 56. Cobra Biologics Viral Vector and Plasmid DNA Product Overview
Table 57. Cobra Biologics Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Cobra Biologics Viral Vector and Plasmid DNA SWOT Analysis
Table 59. Cobra Biologics Business Overview
Table 60. Cobra Biologics Recent Developments
Table 61. FinVector Viral Vector and Plasmid DNA Basic Information
Table 62. FinVector Viral Vector and Plasmid DNA Product Overview
Table 63. FinVector Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. FinVector Business Overview
Table 65. FinVector Recent Developments
Table 66. Lonza Viral Vector and Plasmid DNA Basic Information
Table 67. Lonza Viral Vector and Plasmid DNA Product Overview
Table 68. Lonza Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Lonza Business Overview
Table 70. Lonza Recent Developments
Table 71. BioReliance Viral Vector and Plasmid DNA Basic Information
Table 72. BioReliance Viral Vector and Plasmid DNA Product Overview
Table 73. BioReliance Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. BioReliance Business Overview
Table 75. BioReliance Recent Developments
Table 76. MolMed Viral Vector and Plasmid DNA Basic Information
Table 77. MolMed Viral Vector and Plasmid DNA Product Overview
Table 78. MolMed Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. MolMed Business Overview
Table 80. MolMed Recent Developments
Table 81. FUJIFILM Diosynth Biotechnologies Viral Vector and Plasmid DNA Basic Information
Table 82. FUJIFILM Diosynth Biotechnologies Viral Vector and Plasmid DNA Product Overview
Table 83. FUJIFILM Diosynth Biotechnologies Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. FUJIFILM Diosynth Biotechnologies Business Overview
Table 85. FUJIFILM Diosynth Biotechnologies Recent Developments
Table 86. UniQure Viral Vector and Plasmid DNA Basic Information
Table 87. UniQure Viral Vector and Plasmid DNA Product Overview
Table 88. UniQure Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. UniQure Business Overview
Table 90. UniQure Recent Developments
Table 91. Aldevron Viral Vector and Plasmid DNA Basic Information
Table 92. Aldevron Viral Vector and Plasmid DNA Product Overview
Table 93. Aldevron Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Aldevron Business Overview
Table 95. Aldevron Recent Developments
Table 96. Richter-Helm Viral Vector and Plasmid DNA Basic Information
Table 97. Richter-Helm Viral Vector and Plasmid DNA Product Overview
Table 98. Richter-Helm Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Richter-Helm Business Overview
Table 100. Richter-Helm Recent Developments
Table 101. Eurogentec Viral Vector and Plasmid DNA Basic Information
Table 102. Eurogentec Viral Vector and Plasmid DNA Product Overview
Table 103. Eurogentec Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Eurogentec Business Overview
Table 105. Eurogentec Recent Developments
Table 106. OBiO Technology Viral Vector and Plasmid DNA Basic Information
Table 107. OBiO Technology Viral Vector and Plasmid DNA Product Overview
Table 108. OBiO Technology Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. OBiO Technology Business Overview
Table 110. OBiO Technology Recent Developments
Table 111. Yposkesi Viral Vector and Plasmid DNA Basic Information
Table 112. Yposkesi Viral Vector and Plasmid DNA Product Overview
Table 113. Yposkesi Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Yposkesi Business Overview
Table 115. Yposkesi Recent Developments
Table 116. Cell and Gene Therapy Catapult Viral Vector and Plasmid DNA Basic Information
Table 117. Cell and Gene Therapy Catapult Viral Vector and Plasmid DNA Product Overview
Table 118. Cell and Gene Therapy Catapult Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Cell and Gene Therapy Catapult Business Overview
Table 120. Cell and Gene Therapy Catapult Recent Developments
Table 121. MassBiologics Viral Vector and Plasmid DNA Basic Information
Table 122. MassBiologics Viral Vector and Plasmid DNA Product Overview
Table 123. MassBiologics Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. MassBiologics Business Overview
Table 125. MassBiologics Recent Developments
Table 126. Biovian Viral Vector and Plasmid DNA Basic Information
Table 127. Biovian Viral Vector and Plasmid DNA Product Overview
Table 128. Biovian Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Biovian Business Overview
Table 130. Biovian Recent Developments
Table 131. VGXI Viral Vector and Plasmid DNA Basic Information
Table 132. VGXI Viral Vector and Plasmid DNA Product Overview
Table 133. VGXI Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. VGXI Business Overview
Table 135. VGXI Recent Developments
Table 136. Gene Synthesis Viral Vector and Plasmid DNA Basic Information
Table 137. Gene Synthesis Viral Vector and Plasmid DNA Product Overview
Table 138. Gene Synthesis Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. Gene Synthesis Business Overview
Table 140. Gene Synthesis Recent Developments
Table 141. PlasmidFactory Viral Vector and Plasmid DNA Basic Information
Table 142. PlasmidFactory Viral Vector and Plasmid DNA Product Overview
Table 143. PlasmidFactory Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 144. PlasmidFactory Business Overview
Table 145. PlasmidFactory Recent Developments
Table 146. Jikai Gene Viral Vector and Plasmid DNA Basic Information
Table 147. Jikai Gene Viral Vector and Plasmid DNA Product Overview
Table 148. Jikai Gene Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 149. Jikai Gene Business Overview
Table 150. Jikai Gene Recent Developments
Table 151. Global Viral Vector and Plasmid DNA Sales Forecast by Region (2025-2030) & (K Units)
Table 152. Global Viral Vector and Plasmid DNA Market Size Forecast by Region (2025-2030) & (M USD)
Table 153. North America Viral Vector and Plasmid DNA Sales Forecast by Country (2025-2030) & (K Units)
Table 154. North America Viral Vector and Plasmid DNA Market Size Forecast by Country (2025-2030) & (M USD)
Table 155. Europe Viral Vector and Plasmid DNA Sales Forecast by Country (2025-2030) & (K Units)
Table 156. Europe Viral Vector and Plasmid DNA Market Size Forecast by Country (2025-2030) & (M USD)
Table 157. Asia Pacific Viral Vector and Plasmid DNA Sales Forecast by Region (2025-2030) & (K Units)
Table 158. Asia Pacific Viral Vector and Plasmid DNA Market Size Forecast by Region (2025-2030) & (M USD)
Table 159. South America Viral Vector and Plasmid DNA Sales Forecast by Country (2025-2030) & (K Units)
Table 160. South America Viral Vector and Plasmid DNA Market Size Forecast by Country (2025-2030) & (M USD)
Table 161. Middle East and Africa Viral Vector and Plasmid DNA Consumption Forecast by Country (2025-2030) & (Units)
Table 162. Middle East and Africa Viral Vector and Plasmid DNA Market Size Forecast by Country (2025-2030) & (M USD)
Table 163. Global Viral Vector and Plasmid DNA Sales Forecast by Type (2025-2030) & (K Units)
Table 164. Global Viral Vector and Plasmid DNA Market Size Forecast by Type (2025-2030) & (M USD)
Table 165. Global Viral Vector and Plasmid DNA Price Forecast by Type (2025-2030) & (USD/Unit)
Table 166. Global Viral Vector and Plasmid DNA Sales (K Units) Forecast by Application (2025-2030)
Table 167. Global Viral Vector and Plasmid DNA Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Viral Vector and Plasmid DNA
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Viral Vector and Plasmid DNA Market Size (M USD), 2019-2030
Figure 5. Global Viral Vector and Plasmid DNA Market Size (M USD) (2019-2030)
Figure 6. Global Viral Vector and Plasmid DNA Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Viral Vector and Plasmid DNA Market Size by Country (M USD)
Figure 11. Viral Vector and Plasmid DNA Sales Share by Manufacturers in 2023
Figure 12. Global Viral Vector and Plasmid DNA Revenue Share by Manufacturers in 2023
Figure 13. Viral Vector and Plasmid DNA Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Viral Vector and Plasmid DNA Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Viral Vector and Plasmid DNA Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Viral Vector and Plasmid DNA Market Share by Type
Figure 18. Sales Market Share of Viral Vector and Plasmid DNA by Type (2019-2024)
Figure 19. Sales Market Share of Viral Vector and Plasmid DNA by Type in 2023
Figure 20. Market Size Share of Viral Vector and Plasmid DNA by Type (2019-2024)
Figure 21. Market Size Market Share of Viral Vector and Plasmid DNA by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Viral Vector and Plasmid DNA Market Share by Application
Figure 24. Global Viral Vector and Plasmid DNA Sales Market Share by Application (2019-2024)
Figure 25. Global Viral Vector and Plasmid DNA Sales Market Share by Application in 2023
Figure 26. Global Viral Vector and Plasmid DNA Market Share by Application (2019-2024)
Figure 27. Global Viral Vector and Plasmid DNA Market Share by Application in 2023
Figure 28. Global Viral Vector and Plasmid DNA Sales Growth Rate by Application (2019-2024)
Figure 29. Global Viral Vector and Plasmid DNA Sales Market Share by Region (2019-2024)
Figure 30. North America Viral Vector and Plasmid DNA Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Viral Vector and Plasmid DNA Sales Market Share by Country in 2023
Figure 32. U.S. Viral Vector and Plasmid DNA Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Viral Vector and Plasmid DNA Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Viral Vector and Plasmid DNA Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Viral Vector and Plasmid DNA Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Viral Vector and Plasmid DNA Sales Market Share by Country in 2023
Figure 37. Germany Viral Vector and Plasmid DNA Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Viral Vector and Plasmid DNA Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Viral Vector and Plasmid DNA Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Viral Vector and Plasmid DNA Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Viral Vector and Plasmid DNA Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Viral Vector and Plasmid DNA Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Viral Vector and Plasmid DNA Sales Market Share by Region in 2023
Figure 44. China Viral Vector and Plasmid DNA Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Viral Vector and Plasmid DNA Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Viral Vector and Plasmid DNA Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Viral Vector and Plasmid DNA Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Viral Vector and Plasmid DNA Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Viral Vector and Plasmid DNA Sales and Growth Rate (K Units)
Figure 50. South America Viral Vector and Plasmid DNA Sales Market Share by Country in 2023
Figure 51. Brazil Viral Vector and Plasmid DNA Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Viral Vector and Plasmid DNA Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Viral Vector and Plasmid DNA Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Viral Vector and Plasmid DNA Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Viral Vector and Plasmid DNA Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Viral Vector and Plasmid DNA Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Viral Vector and Plasmid DNA Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Viral Vector and Plasmid DNA Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Viral Vector and Plasmid DNA Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Viral Vector and Plasmid DNA Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Viral Vector and Plasmid DNA Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Viral Vector and Plasmid DNA Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Viral Vector and Plasmid DNA Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Viral Vector and Plasmid DNA Market Share Forecast by Type (2025-2030)
Figure 65. Global Viral Vector and Plasmid DNA Sales Forecast by Application (2025-2030)
Figure 66. Global Viral Vector and Plasmid DNA Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Viral Vector and Plasmid DNA
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Viral Vector and Plasmid DNA Market Size (M USD), 2019-2030
Figure 5. Global Viral Vector and Plasmid DNA Market Size (M USD) (2019-2030)
Figure 6. Global Viral Vector and Plasmid DNA Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Viral Vector and Plasmid DNA Market Size by Country (M USD)
Figure 11. Viral Vector and Plasmid DNA Sales Share by Manufacturers in 2023
Figure 12. Global Viral Vector and Plasmid DNA Revenue Share by Manufacturers in 2023
Figure 13. Viral Vector and Plasmid DNA Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Viral Vector and Plasmid DNA Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Viral Vector and Plasmid DNA Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Viral Vector and Plasmid DNA Market Share by Type
Figure 18. Sales Market Share of Viral Vector and Plasmid DNA by Type (2019-2024)
Figure 19. Sales Market Share of Viral Vector and Plasmid DNA by Type in 2023
Figure 20. Market Size Share of Viral Vector and Plasmid DNA by Type (2019-2024)
Figure 21. Market Size Market Share of Viral Vector and Plasmid DNA by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Viral Vector and Plasmid DNA Market Share by Application
Figure 24. Global Viral Vector and Plasmid DNA Sales Market Share by Application (2019-2024)
Figure 25. Global Viral Vector and Plasmid DNA Sales Market Share by Application in 2023
Figure 26. Global Viral Vector and Plasmid DNA Market Share by Application (2019-2024)
Figure 27. Global Viral Vector and Plasmid DNA Market Share by Application in 2023
Figure 28. Global Viral Vector and Plasmid DNA Sales Growth Rate by Application (2019-2024)
Figure 29. Global Viral Vector and Plasmid DNA Sales Market Share by Region (2019-2024)
Figure 30. North America Viral Vector and Plasmid DNA Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Viral Vector and Plasmid DNA Sales Market Share by Country in 2023
Figure 32. U.S. Viral Vector and Plasmid DNA Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Viral Vector and Plasmid DNA Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Viral Vector and Plasmid DNA Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Viral Vector and Plasmid DNA Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Viral Vector and Plasmid DNA Sales Market Share by Country in 2023
Figure 37. Germany Viral Vector and Plasmid DNA Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Viral Vector and Plasmid DNA Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Viral Vector and Plasmid DNA Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Viral Vector and Plasmid DNA Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Viral Vector and Plasmid DNA Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Viral Vector and Plasmid DNA Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Viral Vector and Plasmid DNA Sales Market Share by Region in 2023
Figure 44. China Viral Vector and Plasmid DNA Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Viral Vector and Plasmid DNA Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Viral Vector and Plasmid DNA Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Viral Vector and Plasmid DNA Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Viral Vector and Plasmid DNA Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Viral Vector and Plasmid DNA Sales and Growth Rate (K Units)
Figure 50. South America Viral Vector and Plasmid DNA Sales Market Share by Country in 2023
Figure 51. Brazil Viral Vector and Plasmid DNA Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Viral Vector and Plasmid DNA Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Viral Vector and Plasmid DNA Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Viral Vector and Plasmid DNA Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Viral Vector and Plasmid DNA Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Viral Vector and Plasmid DNA Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Viral Vector and Plasmid DNA Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Viral Vector and Plasmid DNA Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Viral Vector and Plasmid DNA Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Viral Vector and Plasmid DNA Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Viral Vector and Plasmid DNA Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Viral Vector and Plasmid DNA Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Viral Vector and Plasmid DNA Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Viral Vector and Plasmid DNA Market Share Forecast by Type (2025-2030)
Figure 65. Global Viral Vector and Plasmid DNA Sales Forecast by Application (2025-2030)
Figure 66. Global Viral Vector and Plasmid DNA Market Share Forecast by Application (2025-2030)
